Women's Health Research Program, University of Cincinnati College of Medicine, Ohio, USA.
CNS Spectr. 2009 Oct;14(10 Suppl 8):12-6; discussion 17-8. doi: 10.1017/s1092852900003667.
In summary, new FDA approvals offer options for the treatment of FM. CNS targets have proven to be effective in the treatment of FM. However, treatment must be individualized and the integration of various pharmacologic and nonpharmacologic treatments may be the best approach.
总之,新的 FDA 批准为 FM 的治疗提供了选择。中枢神经系统靶点已被证明在 FM 的治疗中有效。然而,治疗必须个体化,整合各种药物和非药物治疗可能是最好的方法。